NCT04466878View on ClinicalTrials.gov

Prognostic Value of Implementing VCE on Top in Constitutional VWD-patients With GI-bleeding

CompletedOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions

Von Willebrand Diseases

All Listed Sponsors

lead

University Hospital, Lille

OTHER

NCT04466878 - Prognostic Value of Implementing VCE on Top in Constitutional VWD-patients With GI-bleeding | Biotech Hunter | Biotech Hunter